Jan Weller
Dr. med.
Jan Frederic Weller
  • Assistant physician
Working area

Contact

Location

O24
Languages
German (Mother tongue)
English

Publications

2025

Allogeneic hematopoietic cell transplantation after infection with SARS-CoV-2 during the COVID-19 pandemic: a multicenter retrospective analysis
Ahmad O, Kröger N, Wagner-Drouet E, Nachbaur D, Steiner N, Teschner D, Kraus S, Bug G, Ajib S, Schetelig J, Bethge W, Schroeder T, Schaffrath J, Müller L, Verbeek M, Jost E, Soysal H, Tischer J, Franke G, Klein S, Holtick U, Wendelin K, Lengerke C, Bornhäuser M, Weller J, Christopeit M
BONE MARROW TRANSPL. 2025;60(5):733-736.

Clinical stabilization of a highly refractory acute myeloid leukaemia under individualized treatment with immune response modifying drugs by in vivo generation of dendritic cells of leukaemic origin (DCleu) and modulation of effector cells and immune escape mechanisms
Filippini Velázquez G, Anand P, Abdulmajid J, Feng X, Weller J, Hirschbühl K, Schmetzer H, Schmid C
BIOMARK RES. 2025;13(1):104.

Immunological consequences of CAR T-cell therapy: an analysis of infectious complications and immune reconstitution
Riedel A, Phely L, Hug S, Faustmann P, Schröder J, Besemer B, Paczulla Stanger A, Faul C, Lengerke C, Weller J, Bethge W
BLOOD ADV. 2025;9(13):3149-3158.

Prophylactic and pre-emptive donor lymphocyte infusion in patients with acute myeloid leukemia and myelodysplastic syndrome: validation of current recommendations and proposal of a modified outcome assessment
Velázquez G, Weller J, Rubeck A, Arndt T, Schiele S, Mezger M, Lengerke C, Bethge W, Trepel M, Müller G, Christopeit M, Schmid C
HAEMATOLOGICA. 2025 [Epub ahead of print].

58/m nach Chemotherapie - plötzliche nächtliche Verschlechterung: Vorbereitung auf die Facharztprüfung: Fall 54
Weller J, Alsdorf W
ONKOLOGIE-GER. 2025;31(S1):25–30.

Excess mortality of critically ill patients aged ≥90 years in intensive care units: A retrospective cohort study
Weller J, Roedl K, Daniels R, Theile P, Müller J, Peters F, Lengerke C, Bokemeyer C, Wreede L, Kluge S, Christopeit M
EUR J INTERN MED. 2025;137:39-44.

In ageing research the slope matters
Weller J, Wreede L, Roedl K, Peters F, Christopeit M
EUR J INTERN MED. 2025;139:106416.

2024

Impact of Allogeneic Hematopoietic Cell Transplantation Post-Sars-Cov-2 Infection: A Retrospective Analysis By the German Cooperative Transplant Study Group
Ahmad O, Weller J, Kröger N, Drouet E, Nachbaur D, Steiner N, Teschner D, Kraus S, Bug G, Ajib S, Schetelig J, Bethge W, Schroeder T, Schaffrath J, Mueller L, Verbeek M, Jost E, Soysal H, Franke G, Klein S, Holtick U, Wendelin K, Lengerke C, Bornhäuser M, Christopeit M
BLOOD. 2024;144(S1):.

Laminin Receptor Characterization in Acute Myeloid Leukemia: Integrin α7β1 Defines non-Leukemic Stem Cells with Migratory Potential
Görsch E, Arnone M, Klimiankou M, Weller J, Rudat S, Klein G, Lengerke C
2024.

MRC2+ AML Stem Cells Reveal the Role of Proline Metabolism in Venetoclax Resistance
Mills T, Arnone M, Poeschel S, Winter S, Kuebler J, Weller J, Stanger A, Schwab M, Lengerke C
BLOOD. 2024;144(S1):49-50.

Long-Term Immunological Consequences of CD19 CAR T Cell Therapy: Analysis of Infectious Complications and Immune Reconstitution
Riedel A, Weller J, Phely L, Hug S, Faul C, Lengerke C, Bethge W
BLOOD. 2024;144(S1):7248-7249.

Rate of Revision Surgery and Associated Risk Factors After Primary Arthroscopic ACL Repair With Additional Suture Augmentation
Schneider K, Theil C, Gosheger G, Weller J, Goth A, Ahlbaeumer G
ORTHOP J SPORTS MED. 2024;12(5):.

Superior outcome of upfront allogeneic hematopoietic cell transplantation versus hypomethylating agent induction in myelodysplastic syndrome
Schroeder J, Mix L, Faustmann P, Weller J, Fehn A, Phely L, Riedel A, Vogel W, Faul C, Lengerke C, Bethge W
BONE MARROW TRANSPL. 2024;59(9):1332-1334.

Clonal haematopoiesis: A common progenitor for cytotoxic peripheral T-cell lymphoma and angioimmunoblastic T-cell lymphoma
Vogelsberg A, Harland L, Borgmann V, Otto F, Weller J, Nann D, Quintanilla-Martinez L, Fend F
BRIT J HAEMATOL. 2024;204(5):2071-2076.

Allogeneic hematopoietic stem cell transplantation in patients aged 60-79 years in Germany (1998-2018): a registry study
Weller J, Lengerke C, Finke J, Schetelig J, Platzbecker U, Einsele H, Schroeder T, Faul C, Stelljes M, Dreger P, Blau I, Wulf G, Tischer J, Scheid C, Elmaagacli A, Neidlinger H, Flossdorf S, Bornhäuser M, Bethge W, Fleischhauer K, Kröger N, De Wreede L, Christopeit M
HAEMATOLOGICA. 2024;109(2):431-443.

2023

PB1849: EARLY SALVAGE THERAPY WITH VENETOCLAX AND 10-DAY DECITABINE IS FEASIBLE AND SAFE IN REFRACTORY AML: RESULTS FROM 11 PATIENTS WITH EARLY INDUCTION FAILURE
Borst C, Ginsberg F, Weller J, Vogel W, Faul C, Bethge W, Christopeit M, Lengerke C
HEMASPHERE. 2023.

Promising functional outcomes following anterior cruciate ligament repair with suture augmentation
Schneider K, Ahlbäumer G, Gosheger G, Theil C, Weller J, Goth A
KNEE SURG SPORT TR A. 2023;2836-2842.

P1268: ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR HIGH-RISK MYELODYSPLASTIC NEOPLASMS: A RETROSPECTIVE, SINGLE-CENTER ANALYSIS
Schröder J, Faustmann P, Weller J, Faul C, Lengerke C, Bethge W
HEMASPHERE. 2023.

Patients with High-Risk Myelodysplastic Neoplasms Do Not Benefit from Remission Induction with Azacitidine Prior to Hematopoietic Cell Transplantation: A Retrospective, Single-Center Analysis with Extended Follow-up
Schröder J, Weller J, Faustmann P, Mix L, Faul C, Lengerke C, Bethge W
BLOOD. 2023;2231-2232.

2022

Aspirin improves transplant-free survival after TIPS implantation in patients with refractory ascites: a retrospective multicentre cohort study
Seifert L, Schindler P, Sturm L, Gu W, Seifert Q, Weller J, Jansen C, Praktiknjo M, Meyer C, Schoster M, Wilms C, Maschmeier M, Schmidt H, Masthoff M, Köhler M, Schultheiss M, Huber J, Bettinger D, Trebicka J, Wildgruber M, Heinzow H
HEPATOL INT. 2022;16(3):658-668.

2021

Recurrence of hepatic encephalopathy after tips: Effective prophylaxis with combination of lactulose and rifaximin
Seifert L, Schoster M, Weller J, Wilms C, Schmidt H, Maschmeier M, Masthoff M, Köhler M, Heinzow H, Wildgruber M
J CLIN MED. 2021;10(20):4763.

76/w mit subakuter Gangstörung und gelblicher Blässe: Vorbereitung auf die Facharztprüfung: Fall 3
Weller J, Bethge W
ONKOLOGE. 2021;27(Suppl 1):18-26.

Anchor Site Fracture Following Arthroscopic Rotator Cuff Repair - A Case Report and Review of the Literature
Weller J, Birkner B, Schneider K, Durchholz H
Journal of orthopaedic case reports. 2021;11(5):104-108.

Allogeneic Stem Cell Transplantation in Patients Aged ≥70 Years: Epidemiology, Outcomes, and Risk Factors Based on the German Registry for Stem Cell Transplantation (DRST)
Weller J, Kaufmann L, Lengerke C, Finke J, Schetelig J, Platzbecker U, Einsele H, Beelen D, Faul C, Stelljes M, Dreger P, Blau I, Wulf G, Tischer J, Scheid C, Elmaagacli A, Neidlinger H, Frank S, Bornhäuser M, Bethge W, Fleischhauer K, Kröger N, Christopeit M
BLOOD. 2021;138(S1):.

Time-dependent analysis of adoptive immunotherapy following sequential FLAMSA-reduced intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with high-risk myeloid neoplasia
Weller J, Mezger M, Seifert L, Vogel W, Schneidawind D, Faul C, Bethge W, Lengerke C, Christopeit M
EUR J HAEMATOL. 2021;108(3):244-263.

2020

Good to excellent functional short-term outcome and low revision rates following primary anterior cruciate ligament repair using suture augmentation
Schneider K, Schliemann B, Gosheger G, Theil C, Weller J, Buddhdev P, Ahlbäumer G
J CLIN MED. 2020.

2019

Ivabradine Aggravates the Proarrhythmic Risk in Experimental Models of Long QT Syndrome
Frommeyer G, Weller J, Ellermann C, Leitz P, Kochhäuser S, Lange P, Dechering D, Eckardt L
CARDIOVASC TOXICOL. 2019;129-135.

Arthroscopic Anterior Cruciate Ligament Re-Repair Using Internal Brace Augmentation - A Case Report.
Schneider K, Weller J, Buddhdev P, Ahlbäumer G
Journal of orthopaedic case reports. 2019;11-15.

2017

Ivabradine Reduces Digitalis-induced Ventricular Arrhythmias
Frommeyer G, Weller J, Ellermann C, Bögeholz N, Leitz P, Dechering D, Kochhäuser S, Wasmer K, Eckardt L
BASIC CLIN PHARMACOL. 2017;526-530.

Antiarrhythmic properties of ivabradine in an experimental model of Short-QT- Syndrome
Frommeyer G, Weller J, Ellermann C, Kaese S, Kochhäuser S, Lange P, Dechering D, Eckardt L
CLIN EXP PHARMACOL P. 2017;941-945.

Letzte Aktualisierung aus dem FIS: 21.09.2025 - 04:49 Uhr